95 related articles for article (PubMed ID: 7697732)
41. CD73 expression identifies a subset of IgM
D'Souza L; Gupta SL; Bal V; Rath S; George A
Immunology; 2017 Dec; 152(4):602-612. PubMed ID: 28746783
[TBL] [Abstract][Full Text] [Related]
42. Different role of CD73 in leukocyte trafficking via blood and lymph vessels.
Ålgars A; Karikoski M; Yegutkin GG; Stoitzner P; Niemelä J; Salmi M; Jalkanen S
Blood; 2011 Apr; 117(16):4387-93. PubMed ID: 21346249
[TBL] [Abstract][Full Text] [Related]
43. RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion.
Zhi X; Chen S; Zhou P; Shao Z; Wang L; Ou Z; Yin L
Clin Exp Metastasis; 2007; 24(6):439-48. PubMed ID: 17587186
[TBL] [Abstract][Full Text] [Related]
44. Age-dependency of lymphocyte ecto-5'-nucleotidase activity.
Boss GR; Thompson LF; Spiegelberg HL; Pichler WJ; Seegmiller JE
J Immunol; 1980 Aug; 125(2):679-82. PubMed ID: 6248594
[TBL] [Abstract][Full Text] [Related]
45. 5'-nucleotidase activity in lymphocytes from patients affected by B-cell chronic lymphocytic leukemia.
Rosi F; Tabucchi A; Carlucci F; Galieni P; Lauria F; Zanoni L; Guerranti R; Marinello E; Pagani R
Clin Biochem; 1998 Jun; 31(4):269-72. PubMed ID: 9646951
[TBL] [Abstract][Full Text] [Related]
46. Identification of the Mouse T Cell ADP-Ribosylome Uncovers ARTC2.2 Mediated Regulation of CD73 by ADP-Ribosylation.
Leutert M; Duan Y; Winzer R; Menzel S; Tolosa E; Magnus T; Hottiger MO; Koch-Nolte F; Rissiek B
Front Immunol; 2021; 12():703719. PubMed ID: 34504490
[TBL] [Abstract][Full Text] [Related]
47. In Vivo Immunological Effects of CD73 Deficiency.
Adam T; Mathes A; Isayev O; Philippov PP; Werner J; Karakhanova S; Bazhin AV
Cell Physiol Biochem; 2019; 52(5):1192-1202. PubMed ID: 31001959
[TBL] [Abstract][Full Text] [Related]
48. Expression of ecto-5'-nucleotidase (CD73) in normal mammary gland and in breast carcinoma.
Krüger KH; Thompson LF; Kaufmann M; Möller P
Br J Cancer; 1991 Jan; 63(1):114-8. PubMed ID: 1989648
[TBL] [Abstract][Full Text] [Related]
49. CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis.
Mikhailov A; Sokolovskaya A; Yegutkin GG; Amdahl H; West A; Yagita H; Lahesmaa R; Thompson LF; Jalkanen S; Blokhin D; Eriksson JE
J Immunol; 2008 Jul; 181(1):464-75. PubMed ID: 18566412
[TBL] [Abstract][Full Text] [Related]
50. CD73: a novel target for cancer immunotherapy.
Zhang B
Cancer Res; 2010 Aug; 70(16):6407-11. PubMed ID: 20682793
[TBL] [Abstract][Full Text] [Related]
51. Murine ecto-5'-nucleotidase (CD73): cDNA cloning and tissue distribution.
Resta R; Hooker SW; Hansen KR; Laurent AB; Park JL; Blackburn MR; Knudsen TB; Thompson LF
Gene; 1993 Nov; 133(2):171-7. PubMed ID: 8224905
[TBL] [Abstract][Full Text] [Related]
52. Ecto-5'-nucleotidase (CD73): genomic cloning and characterization of regions upstream of the translation start site.
Hansen KR; Resta R; Webb CF; Thompson LF
Adv Exp Med Biol; 1994; 370():689-92. PubMed ID: 7660997
[No Abstract] [Full Text] [Related]
53. 5'-Ectonucleotidase/CD73 expression on lymph-circulating lymphocytes and lymphatic endothelial cells offers new paths to explore barrier function.
Sidibé A; Imhof BA
Eur J Immunol; 2015 Feb; 45(2):371-5. PubMed ID: 25641680
[TBL] [Abstract][Full Text] [Related]
54. Regulation of low Km (ecto-) 5'-nucleotidase gene expression in leukemic cells.
Spychala J; Mitchell BS
Adv Exp Med Biol; 1994; 370():683-7. PubMed ID: 7660996
[No Abstract] [Full Text] [Related]
55. Rheumatoid factor B cell memory leads to rapid, switched antibody-forming cell responses.
Sweet RA; Cullen JL; Shlomchik MJ
J Immunol; 2013 Mar; 190(5):1974-81. PubMed ID: 23365079
[TBL] [Abstract][Full Text] [Related]
56. Anti-5'-nucleotidase antibodies cause human peripheral blood T cells to proliferate.
Thompson LF; Ruedi JM; Low MG
Adv Exp Med Biol; 1989; 253B():157-64. PubMed ID: 2558536
[No Abstract] [Full Text] [Related]
57. Dengue virus type 2 modulates endothelial barrier function through CD73.
Patkar C; Giaya K; Libraty DH
Am J Trop Med Hyg; 2013 Jan; 88(1):89-94. PubMed ID: 23149581
[TBL] [Abstract][Full Text] [Related]
58. 5'-nucleotidase--an overview of the last three years.
Thompson LF
Adv Exp Med Biol; 1991; 309B():145-50. PubMed ID: 1781358
[No Abstract] [Full Text] [Related]
59. NT5E mutations that cause human disease are associated with intracellular mistrafficking of NT5E protein.
Fausther M; Lavoie EG; Goree JR; Baldini G; Dranoff JA
PLoS One; 2014; 9(6):e98568. PubMed ID: 24887587
[TBL] [Abstract][Full Text] [Related]
60. Characterization of mutant clones lacking T-cell receptor alleles in a cell line from an adult T-cell leukaemia patient.
Kusunoki Y; Kyoizumi S; Umeki S; Hirai Y; MacPhee DG
Br J Haematol; 2001 Aug; 114(2):485-7. PubMed ID: 11529874
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
